Chromosome analyses in chronic lymphocytic leukemia and related B-cell neoplasms

T Datta1, M Bauchinger, B Emmerich

  • 1GSF-Forschungszentrum für Umwelt und Gesundheit, Institut für Strahlenbiologie, München-Neuherberg, F.R.G.

Insights

Chromosomal abnormalities are common in B-cell chronic lymphocytic leukemia (B-CLL) and related lymphomas. Trisomy 12 and complex karyotypes were observed, with complex changes correlating with advanced disease stages.

Area of Science:

  • Hematology
  • Cytogenetics
  • Oncology

Background:

  • B-cell chronic lymphocytic leukemia (B-CLL) and related B-cell lymphomas are heterogeneous malignancies.
  • Understanding the cytogenetic landscape is crucial for prognosis and treatment strategies.

Purpose of the Study:

  • To investigate chromosomal abnormalities in patients with B-cell chronic lymphocytic leukemia (B-CLL) and other B-cell lymphomas.
  • To correlate cytogenetic findings with disease stage and clinical outcomes.

Main Methods:

  • Routine G-banding was used for chromosome analysis.
  • Leukemic B-cells were stimulated with 12-O-tetradecanoyl-phorbol-13-acetate (TPA) in 72-hour cultures.
  • Analysis included patients with B-CLL, immunocytoma (IC), centroblastic-centrocytic (cb-cc) lymphoma, and hairy cell leukemia (HCL).

Main Results:

  • Chromosomal abnormalities were detected in 21 out of 29 B-CLL patients and in other lymphoma subtypes.
  • Trisomy 12 was the most frequent abnormality, observed in 7 patients across different B-cell malignancies.
  • Complex karyotypes, including translocations and deletions, were associated with advanced Binet stage C disease and poor prognosis.

Conclusions:

  • Cytogenetic analysis reveals frequent chromosomal aberrations in B-cell lymphoproliferative disorders.
  • Specific abnormalities like trisomy 12 and complex karyotypes have prognostic significance.
  • Further research into the role of these genetic alterations in disease progression is warranted.